Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction - Implications for patients with and without recognized diabetes

被引:490
作者
Kosiborod, M
Rathore, SS
Inzucchi, SE
Masoudi, FA
Wang, YF
Havranek, EP
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[5] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[6] Yale Univ, New Haven Hlth Ctr Outcomes Res & Evaluat, New Haven, CT USA
[7] Denver Hlth Med Ctr, Dept Med, Div Cardiol, Denver, CO USA
关键词
diabetes mellitus; elderly; glucose; mortality; myocardial infarction;
D O I
10.1161/CIRCULATIONAHA.104.517839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The relationship between admission glucose levels and outcomes in older diabetic and nondiabetic patients with acute myocardial infarction is not well defined. Methods and Results - We evaluated a national sample of elderly patients (n = 141 680) hospitalized with acute myocardial infarction from 1994 to 1996. Admission glucose was analyzed as a categorical (<= 110, > 110 to 140, > 140 to 170, > 170 to 240, > 240 mg/dL) and continuous variable for its association with mortality in patients with and without recognized diabetes. A substantial proportion of hyperglycemic patients (eg, 26% of those with glucose > 240 mg/dL) did not have recognized diabetes. Fewer hyperglycemic patients without known diabetes received insulin during hospitalization than diabetics with similar glucose levels (eg, glucose > 240 mg/dL, 22% versus 73%; P < 0.001). Higher glucose levels were associated with greater risk of 30-day mortality in patients without known diabetes ( for glucose range from > 110 to > 240 mg/dL, 10% to 39%) compared with diabetics ( range, 16% to 24%; P for interaction < 0.001). After multivariable adjustment, higher glucose levels continued to be associated with a graded increase in 30-day mortality in patients without known diabetes ( referent, glucose <= 110 mg/dL; range from glucose > 110 to 140 mg/dL: hazard ratio [HR], 1.17; 95% CI, 1.11 to 1.24; to glucose > 240 mg/dL: HR, 1.87; 95% CI, 1.75 to 2.00). In contrast, among diabetic patients, greater mortality risk was observed only in those with glucose > 240 mg/dL ( HR, 1.32; 95% CI, 1.17 to 1.50 versus glucose <= 110 mg/dL; P for interaction < 0.001). One-year mortality results were similar. Conclusions - Elevated glucose is common, rarely treated, and associated with increased mortality risk in elderly acute myocardial infarction patients, particularly those without recognized diabetes.
引用
收藏
页码:3078 / 3086
页数:9
相关论文
共 58 条
  • [1] *AM HOSP ASS, 1979, AHA ANN SURV FISC YE
  • [2] ANTMAN EM, 2005, ACC AHA GUIDELINES M
  • [3] HYPERGLYCEMIA AND PROGNOSIS OF ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITHOUT DIABETES-MELLITUS
    BELLODI, G
    MANICARDI, V
    MALAVASI, V
    VENERI, L
    BERNINI, G
    BOSSINI, P
    DISTEFANO, S
    MAGNANINI, G
    MURATORI, L
    ROSSI, G
    ZUARINI, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (14) : 885 - 888
  • [4] Impaired glucose metabolism predicts mortality after a myocardial infarction
    Bolk, J
    van der Ploeg, T
    Cornel, JH
    Arnold, AER
    Sepers, J
    Umans, VAWM
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 79 (2-3) : 207 - 214
  • [5] ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-Segment elevation myocardial infarction - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
    Braunwald, E
    Antman, EM
    Beasley, JW
    Califf, RM
    Cheitlin, MD
    Hochman, JS
    Jones, RH
    Kereiakes, D
    Kupersmith, J
    Levin, TN
    Pepine, CJ
    Schaeffer, JW
    Smith, EE
    Steward, DE
    Theroux, P
    Gibbons, RJ
    Alpert, JS
    Faxon, DP
    Fuster, V
    Gregoratos, G
    Hiratzka, LF
    Jacobs, AK
    Smith, SC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (07) : 1366 - 1374
  • [6] Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
    Capes, SE
    Hunt, D
    Malmberg, K
    Gerstein, HC
    [J]. LANCET, 2000, 355 (9206) : 773 - 778
  • [7] Management of diabetes and is hyperglycemia in hospitals
    Clement, S
    Braithwaite, SS
    Magee, MF
    Ahmann, A
    Smith, EP
    Schafer, RG
    Hirsh, IB
    [J]. DIABETES CARE, 2004, 27 (02) : 553 - 591
  • [8] The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and those with unspecified hyperglycemia
    Dandona, P
    Aljada, A
    Bandyopadhyay, A
    [J]. DIABETES CARE, 2003, 26 (02) : 516 - 519
  • [9] *DEP HHS, 1989, INT CLASS DIS
  • [10] Metabolic modulation of acute myocardial infarction -: The ECLA glucose-insulin-potassium pilot trial
    Díaz, R
    Paolasso, A
    Piegas, LS
    Tajer, CD
    Moreno, MG
    Corvalán, R
    Isea, JE
    Romero, G
    [J]. CIRCULATION, 1998, 98 (21) : 2227 - 2234